Cara Welch, director of FDA’s Office of Dietary Supplement Programs (ODSP), said her office’s combination with food chemical safety and innovation programs under a restructuring of the agency’s human foods arm will not negatively impact regulation and will instead allow for combining of expertise. Welch spoke Sept. 20 at the Consumer Healthcare Products Association’s Regulatory, Scientific and Quality Conference, providing an update on the dietary supplement office’s work and what will change when the office becomes part of the new...